12th Annual CMHC

October 4-7

Boston, MA

The Cardiometabolic Event of the Year™

12th Annual CMHC Agenda

Schedule is subject to change.

While our 12th Annual CMHC event has concluded, check out the schedule for our upcoming 2018 13th Annual CMHC event

Wednesday, October 24, 2018

Wednesday, October 24, 2018  Women's Health Summit: Cardiometabolic Health Across the Lifespan

10:30 - 10:40 am

Introduction to CMHC Women's Health Summit

Pamela B. Morris, MD

10:40 - 11:10 am

Cardio-oncology: An emerging therapeutic field

Ana Barac, MD

11:10 - 11:40 am

The Intersection Between Breast Cancer and Cardiovascular Disease

Ana Barac, MD

11:40 - 11:55 am

Interactive Participant Q&A Session

Ana Barac, MD

12:00 - 1:00 pm

PME Lunch Symposium (Non-CME)
Sponsored by Amgen, Inc.

1:05 - 1:15 pm

Introduction to CMHC Women’s Health Summit

Pamela B. Morris, MD

1:15 - 1:45 pm

Cardiometabolic Risk in PCOS and Implications for Management

Andrea E. Dunaif, MD

1:45 - 2:15 pm

Impact of Pregnancy on CV Risk Factors and ASCVD Risk

Pam R. Taub, MD

2:15 - 2:30 pm

Nutrition Break

2:30 - 3:00 pm

Choosing Wisely: Contraception in Women with Cardiometabolic Risk

Nieca Goldberg, MD

3:00 - 3:30 pm

Updates on the Role of Postmenopausal Hormone Replacement Therapy

JoAnn E. Manson, MD, DrPH, FAHA

3:30 - 3:50 pm

Women’s Health Summit Expert Panel Discussion and Q&A

Chair:Pamela B. Morris, MD

Panelists: Andrea E. Dunaif, MD
Pam R. Taub, MD
JoAnn E. Manson, MD, DrPH, FAHA

3:50 - 4:00 pm

Conclusions to CMHC Women’s Health Summit

Pamela B. Morris, MD

4:15 - 5:15 pm

PME Session (Non-CME)

5:30 - 6:30 pm

PME Light Bites Session (Non-CME)
Sponsored by Janssen Pharmaceuticals, Inc.

6:45 - 7:45 pm

PME Dinner Symposium (Non-CME)
Sponsored by Amarin Pharma, Inc.

Thursday, October 25, 2018

Thursday, October 25, 2018  CMHC General Sessions

Session I: Diabetes Management

6:30 - 7:45 am

CME Breakfast Symposium

7:55 - 8:00 am

Opening Remarks

Jay S. Skyler, MD

8:00 - 9:30 am

FDA Update and Late Breaking Clinical Trials

Chair:Christie M. Ballantyne, MD

Panelists:Robert H. Eckel, MD
Jay S. Skyler, MD
Keith C. Ferdinand, MD
Deepak L. Bhatt, MD, MPH

9:30 - 10:15 am

KEYNOTE

C. Ronald Kahn, MD

10:15 - 11:15 am

Morning Break - Exhibit Hall

11:15 am - 12:00 pm

So Many Options - Dispelling the Confusion About Insulins

Irl B. Hirsch, MD

12:10 - 1:25 pm

CME Lunch Symposium

1:35 - 2:20 pm

Where Are We with Devices for Diabetes Management?

Anne L. Peters, MD

2:20 - 3:20 pm

Afternoon Break - Exhibit Hall

3:20 - 3:50 pm

How Many GLP1 RAs Do We Need and Why?

John B. Buse, MD

3:50 - 5:05 pm

Multidisciplinary Case Consults

Chair:Jay S. Skyler, MD

Panelists: John B. Buse, MD
Robert H. Eckel, MD
Davida F. Kruger, MSN, APNBC, BCADM
Anne L. Peters, MD
Irl B. Hirsch, MD

5:10 - 6:10 pm

Welcome Reception - Exhibit Hall

6:20 - 7:35 pm

CME Dinner Symposium

7:40 - 8:40 pm

PME Dinner Symposium (Non-CME)

Sponsored by Akcea Therapeutics

Friday, October 26, 2018

Friday, October 26, 2018  CMHC General Sessions

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

6:30 - 7:45 am

CME Breakfast Symposium

7:55 - 8:00 am

Opening Remarks
Robert H. Eckel, MD

8:00 - 8:45 am

Heart Healthy Nutrition

Stephen Devries, MD

8:45 - 9:15 am

Updates on the Microbiome and Metabolic Surgery

Mary-Elizabeth Patti, MD

9:15 - 10:15 am

Morning Break - Exhibit Hall

10:15 - 11:00 am

Obesity and Environmental Influence: The Big Picture

James O. Hill, PhD

11:00 - 11:45 am

Day to Day Management of Obesity in Clinical Practice

Robert F. Kushner, MD

11:45 - 11:50 am

Closing Remarks
Robert H. Eckel, MD

12:00 - 1:15 pm

CME Lunch Symposium

Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction

1:25 - 1:30 pm

Opening Remarks
Christie M. Ballantyne, MD

1:30 - 2:20 pm

Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes

Peter Libby, MD;
Paul M. Ridker, MD

2:20 - 3:20 pm

Afternoon Break - Exhibit Hall

3:20 - 4:10 pm

How Aggressively Do We Lower LDL-C and for Which Patients?

Marc S. Sabatine, MD, MPH;
Vera A. Bittner, MD, MSPH

4:10 - 5:00 pm

Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers

Matthew J. Budoff, MD;
James de Lemos, MD

5:00 - 6:00 pm

Multidisciplinary Case Consults

Chair:Christie M. Ballantyne, MD

Panelists: Robert H. Eckel, MD
Pamela B. Morris, MD
Margo B. Minissian, PhD, ACNP
Pam R. Taub, MD
Vera A. Bittner, MD, MSPH

This session is supported by educational grants from Amarin Pharma, Inc and Akcea Therapeutics.

6:00 - 6:05 pm

Closing Remarks
Christie M. Ballantyne, MD

6:05 - 7:05 pm

Closing Reception - Exhibit Hall

7:15 - 8:15 pm

PME Dinner Symposium (Non-CME)

Sponsored by Novo Nordisk

Saturday, October 27, 2018

Saturday, October 27, 2018  CMHC General Sessions

Session IV: Hypertension, Cardio-renal, and Heart Failure

6:30 - 7:45 am

CME Breakfast Symposium

7:55 - 8:00 am

Opening Remarks
George L. Bakris, MD

8:00 - 9:00 am

Overview of the New 2017 Hypertension Clinical Practice Guidelines

George L. Bakris, MD

9:00 - 9:30 am

Comparing the Hypertension Guidelines - Where is the Equipoise?

William B. White, MD

9:30 - 9:45 am

Nutrition Break

9:45 - 10:45 am

Patient Cases: How would you change the management of hypertension based on the new guidelines?

Keith C. Ferdinand, MD;
Aldo Peixoto, MD;
William B. White, MD

10:45 - 11:15 am

Prevention of Heart Failure: The Next Frontier

Clyde W. Yancy, MD

11:15 - 11:25 am

Mini Break

11:25 - 11:55 am

Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice

Aldo Peixoto, MD

11:55 am - 12:25 pm

AKI and Heart Failure: How to manage compared to general population?

Peter A. McCullough, MD

12:25 - 12:55 pm

Advanced CKD and Benefits From CVOTs

Jorge Plutzky, MD

12:55 - 1:00 pm

Closing Remarks

Return to top